Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF
GNMX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.47B
Close$
$0.20
99.5% downside
Current Fair Value
99.5% downsideOvervalued by 99.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.47 Billion |
|---|---|
| Enterprise Value | $2.97 Billion |
| Earnings per Share | $-0.5 |
| Beta | 2.27 |
| Outstanding Shares | 64,770,000 |
Return
| Return on Equity | -80.89% |
|---|---|
| Return on Assets | -16.87% |
| Return on Invested Capital | -10.17% |
Valuation & Multiples
| P/E Ratio | -76.13 |
|---|---|
| PEG | 350.81 |
| Price to Sales | 12.69 |
| Price to Book Ratio | 19.03 |
| Enterprise Value to Revenue | 12.39 |
| Enterprise Value to EBIT | -37.53 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 2.92 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Corgi ETF Trust I - Corgi ACLS 2x Daily ETF
CEO: David Hunt
ACLZ seeks to deliver 200% of the daily performance of Axcelis Technologies, Inc. (NASDAQ: ACLS), through derivatives such as swap agreements and exchange-traded equity futures to create leveraged exposure. ACLS engages in the manufactur...